Dengue vaccination Knowledge, Attitudes, and Practices among healthcare providers in selected countries from Latin America and Asia Pacific [PDF]
Human Vaccines & ImmunotherapeuticsHealthcare professionals (HCPs) perform an essential role in facilitating dengue vaccine uptake, as they are trusted sources of vaccine information and their perspectives shape both patient acceptance and peer adoption.
Eduardo López-Medina +2 more
doaj +2 more sources
Long-term safety assessment of live attenuated tetravalent dengue vaccines: Deliberations from a WHO technical consultation [PDF]
Vaccine, 2013 Dengue is a rapidly growing public health threat with approximately 2.5 billion people estimated to be at risk. Several vaccine candidates are at various stages of pre-clinical and clinical development.
A. Bentsi-Enchill +7 more
semanticscholar +2 more sources
Dengue Vaccines: Current Status and Future Perspectives
APIK Journal of Internal MedicineDengue fever (DF), caused by the dengue virus (DENV), is a major public health problem worldwide, with approximately 390 million reported annual infections.
Vasantha Kamath, A. B. Aishwarya
doaj +2 more sources
A Novel, Comprehensive A129 Mouse Model for Investigating Dengue Vaccines and Evaluating Pathogenesis. [PDF]
Vaccines (Basel), 2023 In search of a mouse model for use in evaluating dengue vaccines, we assessed A129 mice that lacked IFN-α/β receptors, rendering them susceptible to dengue virus (DENV) infection.
Ngwe Tun MM +9 more
europepmc +2 more sources
Dengue Vaccine Development and Deployment into Routine Immunization
VaccinesDengue has emerged as a significant global health threat. Despite decades of research, only two dengue vaccines—CYD-TDV (Dengvaxia) and TAK-003 (Qdenga)—have been licensed to date, with limited implementation.
Annelies Wilder-Smith +2 more
doaj +2 more sources
Challenges in Dengue Vaccines Development: Pre-existing Infections and Cross-Reactivity. [PDF]
Front Immunol, 2020 Dengue is one of the most frequently transmitted mosquito-borne diseases in the world, which creates a significant public health concern globally, especially in tropical and subtropical countries.
Izmirly AM +4 more
europepmc +2 more sources
Transcutaneous Administration of Dengue Vaccines. [PDF]
Viruses, 2020 In the present study, we evaluated the immunological responses induced by dengue vaccines under experimental conditions after delivery via a transcutaneous (TC) route.
Andreata-Santos R +11 more
europepmc +2 more sources
Anti-dengue Vaccines: From Development to Clinical Trials. [PDF]
Front Immunol, 2020 Dengue Virus (DENV) is an arbovirus (arthropod-borne virus). Four serotypes of DENV are responsible for the infectious disease called dengue that annually affects nearly 400 million people worldwide.
Pinheiro-Michelsen JR +6 more
europepmc +2 more sources
Current status of the development of dengue vaccines. [PDF]
Vaccine XDengue fever is caused by the mosquito-borne dengue virus (DENV), which is endemic in more than 100 countries. Annually, there are approximately 390 million dengue cases, with a small subset manifesting into severe illnesses, such as dengue haemorrhagic ...
Lee MF, Long CM, Poh CL.
europepmc +2 more sources
Dengue Virus and Vaccines: How Can DNA Immunization Contribute to This Challenge?
Frontiers in Medical Technology, 2021 Dengue infections still have a tremendous impact on public health systems in most countries in tropical and subtropical regions. The disease is systemic and dynamic with broad range of manifestations, varying from mild symptoms to severe dengue (Dengue ...
Ada Maria Barcelos Alves +2 more
doaj +1 more source